Select Medical

SEM

Market cap $2.03B

Is the buyout price of $16.50 too low? PHILADELPHIA, April 16, 2026 /PRNewswire/ -- Kaskela Law LLC is investigating the fairness of the recently announced proposed buyout of Select Medical Holdings Corp. ("Select Medical") (NYSE: SEM) shareholders to determine whether the $16.50 per share price is fair to the company's shareholders.

MECHANICSBURG, Pa., April 9, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its first quarter ended March 31, 2026 on Thursday, April 30, 2026 after the market closes.

Kaskela Law is investigating the fairness of the $16.50 per share Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholder buyout.

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is investigating the recently announced buyout of Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholders to determine whether the $16.50 per share buyout offer is fair to the company's investors or if it undervalues the company's shares. Click here for additional information: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a pr.

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Select Medical Holdings Corporation (NYSE: SEM) to a consortium led by Select Medical executives and directors. Under the terms of the proposed transaction, shareholders of Select Medical will receive $16.50 in cash for each share of Select Medical that they own. KSF is seeking to determine whether.

Select Medical jumps 8.4% on a $16.50-per-share take-private deal, but with analyst targets higher, investors may question if the timing leaves upside on the table.

NEW YORK, March 3, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Select Medical Holdings Corporation (NYSE: SEM ) related to its sale to a consortium led by Select Medical executives and directors.

BALA CYNWYD, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Select Medical Holdings Corporation (“Select Medical” or the “Company”) (NYSE - SEM) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to a consortium of entities, including Robert A. Ortenzio, Executive Chairman, Co-Founder and Director of Select Medical for $16.50 per share in cash, representing an enterprise value of $3.9 billion.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Select Medical Holdings Corporation (NYSE: SEM) to a consortium led by Select Medical executives and directors for $16.50 in cash per share. Halper Sadeh encourages Select Medical shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigatio.

MILWAUKEE, March 2, 2026 /PRNewswire/ -- Ademi LLP is investigating Select Medical (NYSE: SEM) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with a consortium led by Executive Chairman Robert A. Ortenzio, Senior Executive Vice President Martin F.